These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1412845)

  • 1. Refractory hypertension in transplant recipients.
    Tripathi K; Prakash J
    Transplant Proc; 1992 Oct; 24(5):1790. PubMed ID: 1412845
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertension after kidney transplantation].
    Racki S
    Lijec Vjesn; 2006; 128(11-12):373-8. PubMed ID: 17212200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 in renal transplant recipients.
    el-Sharabasy MM; el-Naggar MN
    Acta Med Hung; 1991; 48(3-4):225-9. PubMed ID: 1822861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic heart disease after renal transplantation in patients on cyclosporine in Spain.
    Marcén R; Morales JM; Arias M; Fernández-Juárez G; Fernández-Fresnedo G; Andrés A; Rodrigo E; Pascual J; Domínguez B; Ortuño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S286-90. PubMed ID: 17130276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
    Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS
    Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-transplant nephropathy and arterial hypertension].
    Oko A; Idasiak-Piechocka I; Czekalski S
    Przegl Lek; 2001; 58(9):859-63. PubMed ID: 11868248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
    Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
    J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients.
    Gracida C; Melchor JL; Miranda ME; Bartolano C
    Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies.
    Pedersen EB; Madsen JK; Sørensen SS; Zachariae H
    Kidney Int Suppl; 1996 Jun; 55():S94-6. PubMed ID: 8743522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
    Wiener Y; Nakhleh RE; Lee MW; Escobar FS; Venkat KK; Kupin WL; Mozes MF
    Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension in renal transplant recipients on cyclosporin A and corticosteroids and azathioprine.
    Hamilton DV; Carmichael DJ; Evans DB; Calne RY
    Transplant Proc; 1982 Sep; 14(3):597-600. PubMed ID: 6758243
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid profile in renal transplant recipients under various immunosuppressive regimens.
    Montagnino G; Tarantino A; Aroldi A; Banfi G; Cesana B; Ponticelli C
    Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
    Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A
    Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hypertension after transplantation.
    Curtis JJ
    Kidney Int Suppl; 1993 Oct; 43():S45-9. PubMed ID: 8246369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term nephrotoxicity of low doses of cyclosporine in heart transplant recipients.
    Ben Hmida M; Baumelou A; Desruesnnes M; Cabrol A; Pavie A; Grandjbakhch I; Cabrol C
    Transplant Proc; 1995 Oct; 27(5):2725-7. PubMed ID: 7482891
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control.
    Lucini D; Milani RV; Ventura HO; Mehra MR; Messerli FH; Murgo JP; Regenstein F; Copley B; Malliani A; Pagani M
    J Heart Lung Transplant; 1997 Jun; 16(6):615-20. PubMed ID: 9229291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term study on hyperlipidemia in stable renal transplant recipients.
    Tse KC; Lam MF; Yip PS; Li FK; Lai KN; Chan TM
    Clin Transplant; 2004 Jun; 18(3):274-80. PubMed ID: 15142048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients.
    Tsang WK; Ho YW; Tong KL; Chan WH; Chan A
    Transplant Proc; 1996 Jun; 28(3):1330-2. PubMed ID: 8658681
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of immunosuppressive therapy on infectious complications in renal transplant recipients.
    Klauser R; Zlabinger GJ; Traindl O; Franz M; Watschinger B; Pohanka E; Kudlacek S; Kovarik J
    Transplant Proc; 1992 Feb; 24(1):292-4. PubMed ID: 1539284
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of hypertension, hyperlipidemia and cyclosporine A therapy on long-term renal allograft survival.
    Maeda H; Sakamoto K; Kashiwabara H; Hachisu T; Yamada H; Matsushita K; Yamada K; Yokoyama T
    Transplant Proc; 1996 Jun; 28(3):1633-4. PubMed ID: 8658816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.